DNA copy number changes in epithelioid sarcoma and its variants: A comparative genomic hybridization study

被引:14
作者
Lushnikova, T
Knuutila, S
Miettinen, M
机构
[1] Armed Forces Inst Pathol, Dept Soft Tissue Pathol, Washington, DC 20306 USA
[2] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland
[3] Univ Helsinki, Helsinki Univ Hosp, Helsinki, Finland
[4] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia
关键词
cyclin D1; epithelioid sarcoma; genetics;
D O I
10.1038/modpathol.3880203
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Epithelioid sarcoma is a distinctive, rare soft tissue sarcoma that typically involves the distal extremities in young adults, and shows epithelioid morphology and immunohistochemical markers of epithelial differentiation. The genetic background of epithelioid sarcoma is poorly understood, and knowledge of it could give insights into the pathogenesis of this tumor and its possible relationship with other malignant tumors. In this study, we analyzed DNA copy number changes in 30 epithelioid sarcomas by comparative genomic hybridization, DNA was extracted from microdissected samples of formaldehyde-fixed and paraffin-embedded tumors with a minimum of 60% of tumor cells in each sample. Sixteen tumors (53%) showed DNA copy number changes at one to six different genomic sites. The majority of the changes were gains, seen in 14 tumors, whereas 10 tumors showed losses. The most common recurrent gains were at 11q13 (five cases), 1q21-q23 (four cases), 6p21.3 (three cases), and 9q31-qter (three cases). High-level amplifications were detected once in 6p21.3-p21.1 and once in 9q32-qter, Recurrent losses were seen at 9pter-p23 (three cases), 13q22-q32 (three cases), 1p13-p22 (two cases), 3p12-p14 (two cases), 4q13-q33 (two cases), 9p21 (two cases), and 13q32-qter (two cases). The most common recurrent gain at 11q13 was seen in both classic cases and angiomatoid and rhabdoid variants supporting the relationship of these variants with the classic epithelioid sarcoma, Expression of cyclin D1 gene, located in 11q13, was immunohistochemically detected in nine of 15 cases including three of five cases with gain of 11q13, suggesting its involvement in epithelioid sarcoma The observed comparative genomic hybridization changes give targets for future genetic studies on epithelioid sarcoma.
引用
收藏
页码:1092 / 1096
页数:5
相关论文
共 33 条
[1]   VIMENTIN-NEGATIVE EPITHELIOID SARCOMA - THE VALUE OF AN IMMUNOHISTOCHEMICAL PANEL THAT INCLUDES CD34 [J].
ARBER, DA ;
KANDALAFT, PL ;
MEHTA, P ;
BATTIFORA, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (03) :302-307
[2]  
Campo E, 1999, SEMIN HEMATOL, V36, P115
[3]   KERATIN IN EPITHELIOID SARCOMA - AN IMMUNOHISTOCHEMICAL STUDY [J].
CHASE, DR ;
ENZINGER, FM ;
WEISS, SW ;
LANGLOSS, JM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1984, 8 (06) :435-441
[4]   EPITHELIOID SARCOMA - DIAGNOSIS, PROGNOSTIC INDICATORS, AND TREATMENT [J].
CHASE, DR ;
ENZINGER, FM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1985, 9 (04) :241-263
[5]   A NEW CYTOGENETIC FINDING IN AN EPITHELIOID SARCOMA, T(822)(Q22Q11) [J].
CORDOBA, JC ;
PARHAM, DM ;
MEYER, WH ;
DOUGLASS, EC .
CANCER GENETICS AND CYTOGENETICS, 1994, 72 (02) :151-154
[6]  
Courjal F, 1997, CANCER RES, V57, P4368
[7]  
DAIMARU Y, 1987, CANCER, V59, P131
[8]  
El-Rifai W, 1997, LAB INVEST, V77, P699
[9]  
ELNAGGAR AK, 1992, CANCER, V69, P1721, DOI 10.1002/1097-0142(19920401)69:7<1721::AID-CNCR2820690713>3.0.CO
[10]  
2-3